Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Gynecologic 2 Genitourinary 1 Endocrine 1

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Observation 2 Interviews as Topic 2 Fluorouracil 2 Carboplatin 2 Adrenalectomy 2 zimberelimab 1 trametinib 1 lutetium Lu 177 dotatate 1 dabrafenib 1 cemiplimab 1 apatinib 1 anlotinib 1 Watchful Waiting 1 Thyroxine 1 Surveys and Questionnaires 1 Standard of Care 1 Radiomics 1 Radiation 1 Positron Emission Tomography Computed Tomography 1 Mitoxantrone 1 Leucovorin 1 Irinotecan 1 Injections 1 IFL protocol 1 Etoposide 1 Engineering 1 Endoscopic Mucosal Resection 1 Decision Support Techniques 1 Counseling 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × zimberelimab × Endocrine × Clear all

NCT07337447 2026-01-13

REWENEC 01

Hospices Civils de Lyon

Phase 2 Not yet recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡